secwatch.observer — SEC 8-K summary
======================================

Issuer:     OneMedNet Corp (ONMD)
CIK:        0001849380
Form:       8-K
Filed at:   2024-12-30T23:59:59+00:00
Accession:  0001493152-24-052405
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OneMedNet regains Nasdaq compliance after filing overdue quarterly reports
--------------------------------------------------------------------------

- Received Nasdaq notice confirming compliance with Listing Rule 5250(c)(1) after filing Q1-Q3 2024 Form 10-Qs.
- Appointed Bob Golden as interim CFO, hired Director of Business Development and VP of Marketing.
- Signed agreement with Bayer's AI Innovation Platform in early December.
- Raised ~$6.4M in private placements with Off the Chain Capital and Discovery Capital Management affiliate.
- Adopted Bitcoin on balance sheet treasury strategy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1849380/000149315224052405/0001493152-24-052405-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1849380/000149315224052405/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-052405

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer